Zither Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-06-2024
- Paid Up Capital ₹ 0.10 M
as on 20-06-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 59.27%
(FY 2022)
- Profit 72.06%
(FY 2022)
- Ebitda -841.90%
(FY 2022)
- Net Worth 34.78%
(FY 2022)
- Total Assets 47.86%
(FY 2022)
About Zither Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajnish Kumar and Rajat Garg serve as directors at the Company.
- CIN/LLPIN
U24100CH2009PTC031732
- Company No.
031732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zither Pharmaceutical Private Limited offer?
Zither Pharmaceutical Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Malaria Medicine, Industrial Chemicals & Supplies, Biocides, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Nutraceuticals & Dietary Supplements, Mineral Supplement, Common Disease Medicines, Antiseptic Mouthwashes.
Who are the key members and board of directors at Zither Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajnish Kumar  | Director | 22-Sep-2017 | Current |
| Rajat Garg | Director | 22-Sep-2017 | Current |
Financial Performance and Corporate Structure Insights of Zither Pharmaceutical.
Zither Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.27% increase. The company also saw a substantial improvement in profitability, with a 72.06% increase in profit. The company's net worth Soared by an impressive increase of 34.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zither Pharmaceutical?
In 2019, Zither Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Caresfield Pharmaceutical Private Limited
Active
5 years 10 months Rajnish Kumar and Rajat Garg are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zither Pharmaceutical?
Unlock and access historical data on people associated with Zither Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zither Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zither Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
